ArticleMedical physics2025
A device for production of PAGAT dosimetry gel.
Article in Medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A device for production of PAGAT dosimetry gel.Medical physics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundPAGAT (PolyAcrylamide Gelatine gel fabricated at ATmospheric conditions) gel dosimetry provides a valuable three-dimensional (3D) measurement tool for photon therapy, particularly in the context of advanced radiotherapy techniques such as volumetric modulated arc therapy or intensity-modulated radiation therapy. However, the production of PAGAT gel is highly sensitive to variations in the preparation process, particularly in open environments.
methodsTo ensure reliable production of PAGAT gel and a simplified workflow for inexperienced users, a gel preparation device was designed. This device enables (i) single-component preparation, (ii) transfer of gel components, and (iii) filling of gel in 3D-printed vials. The gel batches prepared with this device were analyzed for stability and reproducibility. Furthermore, sensitivity to oxygen exposure was tested with and without Tetrakis(hydroxymethyl)phosphonium chloride (THPC). Additionally, vials used for gel storage and irradiation were fabricated using two different PolyJet 3D printers, with either internal support material (opaque finish) or no internal support material (glossy finish). Post-processing of the printed vials was carried out using either sodium hydroxide (NaOH) cleaning or water rinsing.
resultsThe PAGAT gel produced with this device demonstrated high reproducibility, with a standard error of the mean below 1.8%. The gel remained stable for up to 14 days post-preparation. However, THPC was necessary to remove the residual oxygen from the solution. While the choice of 3D printer did not influence gel performance, the cleaning method played a critical role, with NaOH-cleaned opaque prints showing reduced gel response.
conclusionsThe gel preparation device enabled low-cost PAGAT gel production. The system provided a stable and closed environment to ensure consistent gel properties, reducing variability in dosimetry applications. Its design also offers potential for use with other polymer gel formulations requiring controlled conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.